ENSG00000167323,STIM1,calcium homeostasis,cellular proliferation,tumor progression,angiogenesis,immune evasion,store-operated calcium entry
ENSG00000144935,TRPC1,store-operated calcium entry,calcium signaling pathway,oncogenic proliferation,cell migration,intracellular calcium homeostasis,constitutive activation
ENSG00000089250,NOS1,angiogenesis,cell proliferation,signaling pathway modulation,nitric oxide production,tumor progression,genomic upregulation
ENSG00000058668,ATP2B4,regulation of calcium transport,tumor progression,cell signaling pathways,protein-protein interactions,cell proliferation,apoptosis regulation
ENSG00000069431,ABCC9,apoptosis regulation,cell proliferation,chemotherapy resistance,efflux transporter,ion channel regulation,oncogene upregulation
ENSG00000187486,KCNJ11,cellular excitability,anti-proliferative effects,energy homeostasis regulation,kinase activity regulation,tumorigenesis association,loss-of-function mutations
ENSG00000084754,HADHA,mitochondrial function,energy metabolism,redox balance alteration,tumor microenvironment regulation,hif transcriptional regulation,glycolytic shift
ENSG00000138029,HADHB,mitochondrial function,oxidative stress,energy metabolism regulation,fatty acid oxidation impairment,cellular adaptation enhancement,mitochondrial dynamics alteration
ENSG00000197265,GTF2E2,transcriptional regulation,aberrant overexpression,cell cycle progression,apoptosis modulation,dna repair dysregulation,gene expression enhancement
ENSG00000153767,GTF2E1,tfii-e complex regulation,transcription initiation,cell proliferation enhancement,dna repair modulation,apoptosis inhibition,oncogenic driver
ENSG00000140307,GTF2A2,transcriptional regulation,overexpression,tumor progression,gene expression modulation,cellular metabolism alteration,prognostic biomarker
ENSG00000165417,GTF2A1,genetic instability,regulatory mechanism disruption,transcriptional dysregulation,cellular proliferation enhancement,oncogenic potential increase,transcription factor binding site alteration
ENSG00000162738,VANGL2,planar cell polarity signaling,dysregulated expression,metastasis promotion,cell invasion,tumor aggressiveness,poor prognosis
ENSG00000274287,SCRIB,scrib regulates epithelial polarity,altered protein-protein interaction,loss of cell-cell adhesion,tumor progression and aggressiveness,oncogenic signaling pathways,cell survival and proliferation
ENSG00000004975,DVL2,wnt signaling pathway,oncogenic processes,cell proliferation,cell migration,tcf/lef transcription factors,growth factor regulation
ENSG00000102981,PARD6A,disruption of cell polarity,cell cycle regulation,oncogenic process,protein-protein interaction,tumor suppression,cytokinesis regulation
ENSG00000177885,GRB2,oncogenic signaling,rtk activation,cell proliferation,metastasis promotion,angiogenesis regulation,adaptor function
ENSG00000109458,GAB1,pi3k/akt/mtor pathway,constitutive activation,cell signaling regulation,tumor progression,scaffolding protein function,apoptosis resistance
ENSG00000146648,EGFR,activating mutations,constitutive activation,cancer driver gene,enhanced cell proliferation,increased angiogenesis,ras/raf/mapk pathway
ENSG00000138798,EGF,egf signaling pathway,oncogenic potential,epithelial-to-mesenchymal transition (emt),cell proliferation,angiogenesis,apoptosis inhibition
ENSG00000121879,PIK3CA,pi3k/akt signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000145675,PIK3R1,constitutive activation,signaling pathway regulation,oncogenic driver,cell survival enhancement,tumor microenvironment modulation,immune response regulation
ENSG00000197122,SRC,tumor progression,metastasis,constitutive activation,cell proliferation,angiogenesis,growth regulation
ENSG00000089159,PXN,focal adhesion disruption,oncogenic signaling pathway,cell migration facilitation,metastasis promotion,actin cytoskeleton regulation,protein-protein interaction hotspot
ENSG00000137392,CLPS,lipid digestion,metabolic regulation,enzymatic activity,lipolysis,dietary fat absorption,cellular proliferation
ENSG00000175535,PNLIP,lipid metabolism alterations,tumor progression,cellular energy modulation,lipid-dependent signaling,triglyceride synthesis,fatty acid storage
ENSG00000078369,GNB1,cell signaling pathway disruption,g protein subunit interaction,oncogenic protein association,tumor growth promotion,metastasis facilitation,therapeutic target identification
ENSG00000127928,GNGT1,g-protein coupled receptor signaling,aberrant activation,mutations leading to oncogenesis,cell proliferation regulation,protein kinase activation regulation,camp signaling dysregulation
ENSG00000198515,CNGA1,oncogene activity,aberrant expression,tumor progression,cell proliferation,apoptosis resistance,therapeutic target
ENSG00000070729,CNGB1,cellular response regulation,gain of function mutations,pi3k/akt signaling pathway interaction,therapeutic target,oncogenic process enhancement,cell growth modulation
ENSG00000257365,FNTB,fatty acid elongation,lipid signaling pathway,cell membrane composition,metabolic reprogramming,tumor aggressiveness,genomic amplification
ENSG00000168522,FNTA,fatty acid metabolism,redox balance regulation,cell survival promotion,oxidative stress tolerance,angiogenesis modulation,immune evasion support
ENSG00000113522,RAD50,genomic instability,dna damage response,mrn complex,non-homologous end joining (nhej),scaffold protein function,double-strand break repair
ENSG00000020922,MRE11,genomic instability,dna repair mechanism,telomere maintenance,oncogenic process,cancer driver gene,genome stability
ENSG00000182481,KPNA2,nuclear transport,cell proliferation,protein import,chromatin remodeling,transcriptional regulation,aggressive tumor behavior
ENSG00000104320,NBN,genomic instability,dna repair regulation,homologous recombination repair,gain of function mutation,cell cycle regulation,tumor progression
ENSG00000172977,KAT5,genomic instability,cell cycle progression,tumor suppressor degradation,cancer cell proliferation,rna acetylation,dna repair regulation
ENSG00000149311,ATM,genomic stability,dna damage response,radiation sensitivity,cancer susceptibility,apoptosis activation,cell cycle regulation
ENSG00000009954,BAZ1B,chromatin remodeling,dna repair facilitation,genomic instability induction,cell proliferation promotion,oncogene activation,tumor suppressor inhibition
ENSG00000153147,SMARCA5,genomic instability,chromatin remodeling,swi/snf complex activation,oncogenic pathway activation,tumor progression,therapeutic target
ENSG00000103275,UBE2I,ubiquitination regulation,protein degradation,cell cycle progression,apoptosis modulation,tumor suppressor dysfunction,cancer cell survival
ENSG00000116030,SUMO1,oncogenic signaling,tumor progression,resistance to apoptosis,cell cycle regulation,protein modification,transcriptional regulation
ENSG00000169139,UBE2V2,protein degradation pathway,ubiquitin conjugation,cell cycle regulation,tumor progression,cancer driver gene candidate,genomic instability
ENSG00000177889,UBE2N,protein degradation,cell cycle regulation,transcriptional control,dna repair,oncogenesis,tumor progression
ENSG00000138376,BARD1,genomic instability,tumor progression,dna repair mechanisms,homologous recombination,mutations accumulation,epigenetic regulation
ENSG00000012048,BRCA1,homologous recombination,genomic instability,dna repair defects,tumor suppressor function,cell cycle regulation,apoptosis resistance
ENSG00000188612,SUMO2,p53 stabilization,tumor suppression,cell cycle arrest,dna repair mechanisms,protein modification,transcriptional regulation
ENSG00000225589,MDC1,genomic stability,dna repair pathway,chromatin remodeling,cell cycle regulation,scaffold protein function,apoptosis modulation
ENSG00000128731,HERC2,pi3k/akt pathway,ubiquitination and degradation,oncogenic function,tumor suppressor regulation,cell proliferation,signaling pathway interaction
ENSG00000164053,ATRIP,atr/atm regulation,cancer genome instability,dna repair mechanism disruption,genomic integrity maintenance defect,proliferation and survival enhancement,tumor suppressor function attenuation
ENSG00000175054,ATR,cell cycle regulation,gene amplification,dna replication stress,chemosensitivity loss,tumor growth promotion,pro-survival pathway activation
ENSG00000111602,TIMELESS,genetic instability,chromatin remodeling,dna repair regulation,cell proliferation promotion,therapeutic resistance,poor prognosis association
ENSG00000075131,TIPIN,genomic instability,replication-coupled nucleotide excision repair,interacts with xpc and xpb,tumor suppressor function,dna damage response,genome stability maintenance
ENSG00000163605,PPP4R2,pp4 dephosphorylation,enhanced cell proliferation,tumor metastasis,oncogenic protein stabilization,therapeutic target,apoptosis suppression
ENSG00000149923,PPP4C,chromatin remodeling,dephosphorylation,genomic instability,histone modification,prognostic marker,tumor progression
ENSG00000108384,RAD51C,genomic instability,homologous recombination repair,dna repair,chromosomal integrity,cancer susceptibility,synthetic lethality therapy
ENSG00000126215,XRCC3,genomic instability,dna repair mechanism,homologous recombination,non-homologous end joining,cancer susceptibility,chromosomal instability
ENSG00000197774,EME2,dna replication regulation,genetic instability prevention,caretaker tumor suppressor,oncogenic potential,cell cycle progression,genome stability maintenance
ENSG00000172732,MUS81,genomic instability,interstrand crosslink repair,dna double-strand break repair,homologous recombination,non-homologous end joining,tumor progression
ENSG00000154920,EME1,dna repair deficiency,genomic instability,nucleotide excision repair,oncogenesis,tumor progression,gene expression regulation
ENSG00000139618,BRCA2,genomic instability,loss of function mutations,tumor suppressor function,dna repair mechanism,homologous recombination,oncogenesis
ENSG00000051180,RAD51,genomic instability,tumor progression,dna repair dysfunction,oncogenic activation,rad51 mutations,genetic alterations
ENSG00000175595,ERCC4,genomic instability,mutation-induced dna damage,tumor progression,impaired dna repair,ner pathway dysregulation,bulky dna lesion removal
ENSG00000012061,ERCC1,dna damage response,tumor suppressor function,genome instability,nucleotide excision repair pathway,platinum-based chemotherapy resistance,cancer progression
ENSG00000073050,XRCC1,base excision repair,dna damage response,genome stability maintenance,parp1 interaction,tumor suppressor function,epigenetic regulation
ENSG00000005156,LIG3,genomic instability,double-strand breaks repair,dna repair enzyme activity,nhej pathway activation,tumor suppressor function loss,cell cycle regulation disruption
ENSG00000196419,XRCC6,dna repair mechanism,apoptosis modulation,genomic instability,tumor progression,cancer cell survival,chemosensitivity regulation
ENSG00000079246,XRCC5,dna repair deficiency,genomic instability,impaired nhej function,tumor suppressor loss,cell cycle regulation,oncogenic mutations
ENSG00000152422,XRCC4,genetic instability,dna repair pathway,chromosomal rearrangements,tumor progression,gene interaction,genome integrity maintenance
ENSG00000174405,LIG4,genetic instability,non-homologous end joining pathway,double-strand breaks repair,dna damage response,genomic stability maintenance,tumor suppressor function
ENSG00000049860,HEXB,hexb catalyzes glucocerebroside hydrolysis,tumor suppressor function,regulates glycosphingolipid metabolism,impact on cellular processes,aberrant glycosylation patterns,alters gene expression profiles
ENSG00000213614,HEXA,lysosomal storage disorder,tay-sachs disease,metabolic regulation,aerobic glycolysis,lysosomal function,cellular metabolism
ENSG00000151348,EXT2,heparan sulfate biosynthesis,oncogene potential,extracellular matrix regulation,tumor progression and invasion,cell signaling and proliferation,glycosaminoglycan modification
ENSG00000182197,EXT1,heparan sulfate proteoglycans,cell growth regulation,proteoglycan biosynthesis,tumor progression,microenvironment modulation,glycosylation process
ENSG00000115904,SOS1,ras pathway dysregulation,gef activity enhancement,tumor progression driver,cell proliferation promoter,survival signal activation,signaling pathway interaction
ENSG00000170312,CDK1,cell proliferation,g2/m checkpoint,tumor growth,autophagy regulation,cancer progression,apoptosis induction
ENSG00000134057,CCNB1,cell cycle regulation,cyclin-dependent kinase activation,chromosomal instability,tumor progression,therapeutic target,mitotic spindle formation
ENSG00000165494,PCF11,genomic instability,dna replication,cell cycle regulation,oncogenic driver,chromatin remodeling,genome maintenance
ENSG00000172409,CLP1,telomere maintenance,genomic instability,tumor aggressiveness,chromosomal fusions,therapeutic target,cancer driver gene
ENSG00000187079,TEAD1,tumor aggressiveness,oncogene activation,cell cycle progression,epithelial-to-mesenchymal transition (emt),chromatin remodeling,transcriptional reprogramming
ENSG00000137693,YAP1,constitutive activation,hippo signaling pathway,transcriptional coactivation domain,oncogenic driver,epithelial-to-mesenchymal transition,cellular metabolism
ENSG00000074219,TEAD2,hippo signaling pathway,transcriptional regulation,oncogenic driver,constitutive activation,cell proliferation,tumor progression
ENSG00000007866,TEAD3,transcriptional regulation,oncogene function,cell cycle progression,apoptosis inhibition,tumor aggressiveness,genetic alterations
ENSG00000197905,TEAD4,hippo signaling pathway,transcriptional regulation,epithelial-to-mesenchymal transition,oncogenic transcription factor,tumor progression,cell proliferation
ENSG00000132964,CDK8,transcriptional regulation,protein kinase activation,cell cycle progression,apoptosis regulation,dna damage response,oncogenic driver
ENSG00000112237,CCNC,dna damage response,g1-s phase transition,transcriptional regulation,cell proliferation,oncogenic properties,cancer prognosis
ENSG00000101665,SMAD7,tgf-β pathway regulation,gene expression modulation,tumor suppression function,apoptosis regulation,ectopic expression,protein degradation inhibition
ENSG00000157450,RNF111,apoptosis regulation,cell cycle progression,dna damage response,oncogenic protein modulation,p53 degradation,therapeutic target
ENSG00000284792,PTEN,loss-of-function mutation,pi3k/akt pathway inhibition failure,oncogenic driver,constitutive activation,tumor suppressor function loss,cell cycle regulation impairment
ENSG00000141510,TP53,genomic stability maintenance,tumor suppressor function,dna damage response,cell cycle regulation,apoptosis induction,oncogenesis prevention
ENSG00000165699,TSC1,gain of function mutations,tumor suppression,mechanistic target of rapamycin (mtor) pathway,cellular proliferation,cellular survival,therapeutic target
ENSG00000103197,TSC2,mtor signaling pathway,constitutive activation,loss of tumor suppressor function,cell growth promotion,proliferation regulation,metabolic dysregulation
ENSG00000284194,SCO2,mitochondrial biogenesis,tumor aggressiveness,energy metabolism,overexpression,oncogenic process,tumorigenesis
ENSG00000048392,RRM2B,dna synthesis,constitutive expression,cell proliferation,genomic instability,oncogene activation,therapeutic target
ENSG00000135423,GLS2,metabolic reprogramming,tumor growth promotion,therapeutic target,glutamine metabolism regulation,ammonia detoxification enhancement,cell survival promotion
ENSG00000146674,IGFBP3,igf-binding activity,cell growth regulation,tumor suppression,apoptosis induction,dna damage response,genetic instability
ENSG00000141682,PMAIP1,apoptosis regulation,pro-apoptotic function,bcl-2 family interactions,mitochondrial outer membrane permeabilization,p53 pathway regulation,transcriptional targeting
ENSG00000015475,BID,apoptosis regulation,bh3-interacting domain,pro-apoptotic function,mitochondrial pathway activation,caspase activation,cellular resistance to death
ENSG00000120471,TP53AIP1,tp53 pathway modulation,apoptosis suppression,cell survival enhancement,tumor suppressor interaction,prognostic marker alteration,p53 protein regulation
ENSG00000197050,ZNF420,tumor suppressor,transcriptional regulation,cell proliferation,chromatin remodeling,histone modification,dna methylation
ENSG00000115107,STEAP3,iron metabolism,hypoxic microenvironment,reactive oxygen species (ros),tumor progression,cell signaling pathways,metalloreductase activity
ENSG00000104765,BNIP3L,mitochondrial dysfunction,mitophagy activation,oxidative stress induction,cellular adaptation,protein-protein interactions,genetic instability
ENSG00000170855,TRIAP1,histone modification,chromatin remodeling,tumor progression,transcriptional regulation,prognostic marker,oncogenic interaction
ENSG00000042286,AIFM2,mitochondrial dynamics,dna damage response,apoptosis evasion,cellular metabolism,therapeutic target,biomarker for treatment response
ENSG00000164938,TP53INP1,tumor suppressor activity,p53 regulation,apoptosis induction,genomic instability prevention,dna repair modulation,cell cycle regulation
ENSG00000120868,APAF1,apoptosis regulation,mitochondrial pathway,caspase-9 activation,cell cycle progression,dna repair mechanisms,cancer stem cells maintenance
ENSG00000177595,PIDD1,apoptosis regulation,genomic stability maintenance,tumor suppressor function,cell cycle arrest modulation,caspase activation,pi3k/akt pathway interaction
ENSG00000169372,CRADD,apoptosis regulation,tumor suppressor activity,ripk1-ripk3 complex formation,cell death signaling,cancer resistance,genetic mutation association
ENSG00000091106,NLRC4,immune modulation,tumor microenvironment modulation,oncogenic inflammation,cell proliferation enhancement,protein-protein interaction regulation,nf-κb activation pathway
ENSG00000138794,CASP6,apoptosis regulation,proteolytic activation,cancer cell survival,oncogenic driver,cell proliferation promotion,therapeutic target
ENSG00000003400,CASP10,apoptosis regulation,proteolytic activation,cell death execution,tumor suppressor function,extrinsic pathway modulation,cancer cell survival
ENSG00000104419,NDRG1,dual role,tumor suppressor function,cell proliferation regulation,pi3k/akt pathway regulation,cell differentiation regulation,gene expression modulation
ENSG00000281449,BCL2L14,apoptosis regulation,cell survival modulation,mitochondrial function regulation,oncogenic process promotion,tumor progression facilitation,therapeutic target consideration
ENSG00000089685,BIRC5,tumor progression,therapeutic target,apoptosis regulation,cell cycle regulation,protein-protein interactions,oncogenic processes
ENSG00000113916,BCL6,transcriptional repressor,oncogene activation,apoptosis suppression,cell cycle progression,tumor cell survival,genetic deregulation
ENSG00000161642,ZNF385A,overexpression,transcription regulation,genomic instability,cell proliferation,apoptosis inhibition,tumor progression
ENSG00000116017,ARID3A,genomic instability,tumor suppressor function,chromatin remodeling,cell cycle regulation,transcriptional modulation,protein-protein interaction
ENSG00000165891,E2F7,transcriptional regulation,cell cycle dysregulation,oncogenesis,tumor suppressor function,cell proliferation regulation,chromatin remodeling
ENSG00000129173,E2F8,cell cycle regulation,dysregulated expression,tumor suppressor modulation,apoptosis resistance,protein-protein interactions,transcriptional regulation
ENSG00000116717,GADD45A,tumor suppressor,cell cycle regulation,dna repair mechanisms,apoptosis induction,transcriptional control,genome stability maintenance
ENSG00000087586,AURKA,cell division regulation,centrosome separation,mitosis,tumorigenesis promoter,genomic instability contributor,cell cycle progression enhancer
ENSG00000132646,PCNA,cell proliferation,dna replication,genomic instability,proliferation marker,cell cycle regulation,dna repair mechanism
ENSG00000087088,BAX,apoptosis regulation,tumor suppressor function,pro-apoptotic protein,mitochondrial outer membrane permeabilization,cell survival inhibition,chemotherapy resistance modulation
ENSG00000175793,SFN,oncogenic properties,tumor aggressiveness,cell survival and proliferation,apoptosis suppression,microtubule stabilization,genomic stability regulation
ENSG00000145632,PLK2,cell cycle progression,polo-like kinase function,apoptosis inhibition,tumor growth promotion,angiogenesis regulation,dna repair modulation
ENSG00000173846,PLK3,cell cycle regulation,overexpression,proliferation regulation,cyclin-dependent kinase interaction,checkpoint kinase modulation,tumor aggressiveness
ENSG00000102760,RGCC,chromatin remodeling,g2/m phase transition regulation,gain of function mutations,cellular proliferation enhancement,chromosome instability,oncogenic process contribution
ENSG00000118495,PLAGL1,cellular differentiation,constitutive activation,enhanced cell proliferation,genomic instability,oncogenic process,regulatory element interaction
ENSG00000115966,ATF2,transcriptional regulation,constitutive activation,oncogenic transformation,cell cycle progression,apoptosis inhibition,protein dimerization
ENSG00000177606,JUN,transcriptional regulation,proliferation promotion,oncogenesis activation,cell migration enhancement,survival pathway interaction,mapk/erk signaling modulation
ENSG00000170345,FOS,cell proliferation,transcriptional regulation,oncogene activation,tumor progression,apoptosis inhibition,genomic instability
ENSG00000122512,PMS2,mmr pathway disruption,genetic instability,deficiency leading to carcinogenesis,tumor progression,impaired dna repair,increased mutation burden
ENSG00000076242,MLH1,dna mismatch repair pathway,genetic instability,microsatellite instability,tumor suppressor function,oncogenesis initiation,prognostic marker
ENSG00000158169,FANCC,genomic instability,cell cycle regulation,dna repair deficiency,tumorigenesis,cancer predisposition,metastatic potential
ENSG00000134574,DDB2,genomic instability,dna repair deficiency,oncogenic mutations,tumor suppressor function,ner pathway disruption,xpc interaction
ENSG00000057657,PRDM1,transcriptional regulator,immune surveillance,tumor suppressor gene,methylated or mutated,cell cycle regulation,apoptosis and dna repair
ENSG00000135679,MDM2,p53 regulation,tumor suppressor protein inhibition,cell cycle arrest disruption,apoptosis evasion,protein stabilization,genomic amplification
ENSG00000198625,MDM4,p53 inhibition,tumor suppressor inactivation,cell cycle progression,apoptosis evasion,transcriptional regulation,oncogenic protein stabilization
ENSG00000113328,CCNG1,p53 inhibition,oncogene overexpression,pi3k/akt pathway activation,cell cycle progression regulation,dna damage response disruption,genomic instability promotion
ENSG00000064393,HIPK2,pi3k/akt signaling pathway activation,cell survival regulation,apoptosis inhibition,dna damage response modulation,epithelial-to-mesenchymal transition promotion,tumor growth enhancement
ENSG00000127445,PIN1,prolyl cis/trans isomerization,transcriptional regulation,oncogene/tumor suppressor function,apoptosis evasion,cell cycle progression,therapeutic target
ENSG00000163349,HIPK1,apoptosis regulation,genome stability maintenance,tumor suppressor function,cell growth modulation,protein-protein interaction,cellular signaling pathway
ENSG00000149136,SSRP1,chromatin remodeling,transcriptional activation,cell growth regulation,oncogenic overexpression,pi3k/akt pathway interaction,tumor suppressor function
ENSG00000092201,SUPT16H,chromatin remodeling,transcriptional regulation,cell cycle progression,apoptosis evasion,histone acetyltransferase activity,prognostic marker
ENSG00000101266,CSNK2A1,tumor progression,cell proliferation regulation,oncogenic signaling pathway activation,apoptosis suppression,transcriptional control,cancer drug resistance
ENSG00000070770,CSNK2A2,ck2 holoenzyme regulation,cell cycle progression,protein phosphorylation,oncogenic transformation,tumor migration,therapeutic target
ENSG00000088325,TPX2,microtubule regulation,oncogenic role,tumor progression,cell proliferation enhancement,signaling pathway interaction,spindle assembly facilitation
ENSG00000188976,NOC2L,genomic stability,chromatin remodeling,cell cycle regulation,nucleolar complex assembly,genetic instability,oncogenic mutations
ENSG00000176749,CDK5R1,aberrant activation,cell cycle progression,emt regulation,metastasis promotion,oncogenic driver,poor prognosis
ENSG00000164885,CDK5,cell cycle regulation,apoptosis modulation,enhanced cell proliferation,tumor suppressor function,potential oncogenic driver,genomic instability
ENSG00000152192,POU4F1,cell cycle regulation,epithelial-to-mesenchymal transition,transcription factor activity,tumor progression,oncogenic processes,enhanced cell proliferation
ENSG00000151615,POU4F2,transcriptional regulation,cell proliferation,tumor growth,apoptosis evasion,gene expression regulation,neural cell development
ENSG00000172530,BANP,dna repair mechanisms,transcription factor,genomic instability,cell proliferation,apoptosis inhibition,tumor suppressor
ENSG00000025293,PHF20,histone modification,overexpression,microrna processing,tumor progression,cell proliferation,chromatin remodeling
ENSG00000185513,L3MBTL1,loss of function mutations,chromatin regulation,tumor suppression,cell cycle regulation,dna repair mechanism,apoptosis modulation
ENSG00000238134,EHMT2,epigenetic regulation,histone methylation,gene silencing,tumor suppressor downregulation,chromatin modification,cancer progression
ENSG00000181090,EHMT1,histone methylation,epigenetic regulation,genomic instability,tumor suppressor silencing,proto-oncogene activation,cell cycle regulation
ENSG00000137203,TFAP2A,transcriptional regulation,tumor suppressor activity,cell proliferation,oncogenic driver,gene overexpression,wnt/β-catenin pathway interaction
ENSG00000124795,DEK,oncogene,chromatin remodeling,transcription regulation,cell cycle progression,apoptosis suppression,prognostic biomarker
ENSG00000087510,TFAP2C,cell cycle regulation,transcriptional activation,tumor progression,metastasis,oncogene overexpression,genomic instability
ENSG00000186153,WWOX,chromosomal instability,dna damage repair defects,tumor suppressor function,apoptosis regulation,cell cycle progression,genomic stability maintenance
ENSG00000008196,TFAP2B,tfap2b regulation,transcriptional modulation,pi3k/akt pathway interaction,tumor suppressor activity,cellular proliferation,genomic instability
ENSG00000127337,YEATS4,chromatin remodeling,oncogene,cell proliferation,transcriptional regulation,epigenetic modification,acetylated histone binding
ENSG00000091831,ESR1,estrogen-dependent transcription,constitutive activation,gain of function mutations,tumor progression,therapeutic target,gene amplification
ENSG00000156802,ATAD2,oncogene,chromatin remodeling,epithelial-to-mesenchymal transition (emt),cell proliferation,genomic instability,dna damage
ENSG00000112715,VEGFA,angiogenesis promotion,tumor progression,overexpression,cell proliferation,endothelial cell interaction,vasculature formation
ENSG00000163235,TGFA,egf signaling pathway,cell surface receptor activation,oncogenic growth factor,cell proliferation enhancement,metastasis promotion,tumor microenvironment interaction
ENSG00000124762,CDKN1A,cell cycle regulation,cyclin-dependent kinase inhibition,tumor suppressor function,genomic stability maintenance,oncogenesis driver,dna damage response modulation
ENSG00000159216,RUNX1,hematopoiesis,transcriptional regulation,gene expression alterations,tumor growth promotion,cancer development,dysregulation
ENSG00000078900,TP73,cellular apoptosis,cell cycle regulation,tumor suppressor function,genomic instability,oncogenesis,therapeutic target
ENSG00000179588,ZFPM1,tumor suppressor,downregulation,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway interaction,transcription regulation,cancer initiation
ENSG00000102145,GATA1,transcriptional regulator,oncogene potential,overexpression,cell cycle regulation,apoptosis modulation,hematopoietic differentiation
ENSG00000143387,CTSK,cathepsin activity,osteoclast differentiation,extracellular matrix degradation,tumor progression,metastasis promotion,angiogenesis facilitation
ENSG00000197641,SERPINB13,tumor suppressor function,loss of expression,apoptosis inhibition,angiogenesis regulation,cell migration inhibition,metastasis suppression
